Report Detail
Global Serine/Threonine Protein Kinase Chk1 Market Insights, Forecast to 2025
- RnM2850495 |
- 18 February, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
The global Serine/Threonine Protein Kinase Chk1 market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Serine/Threonine Protein Kinase Chk1 market based on company, product type, end user and key regions.
This report studies the global market size of Serine/Threonine Protein Kinase Chk1 in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Serine/Threonine Protein Kinase Chk1 in these regions.
This research report categorizes the global Serine/Threonine Protein Kinase Chk1 market by top players/brands, region, type and end user. This report also studies the global Serine/Threonine Protein Kinase Chk1 market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
CanBas Co Ltd
Cascadian Therapeutics Inc
Eli Lilly and Company
Genentech Inc
ProNAi Therapeutics Inc
Sareum Holdings Plc
Vernalis Plc
Market size by Product
CCT-244747
FS-105
GDC-0575
Others
Market size by End User
Clinic
Hospital
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Serine/Threonine Protein Kinase Chk1 market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Serine/Threonine Protein Kinase Chk1 market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Serine/Threonine Protein Kinase Chk1 companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Serine/Threonine Protein Kinase Chk1 submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Serine/Threonine Protein Kinase Chk1 are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Serine/Threonine Protein Kinase Chk1 market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Serine/Threonine Protein Kinase Chk1 Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Serine/Threonine Protein Kinase Chk1 Market Size Growth Rate by Product
- 1.4.2 CCT-244747
- 1.4.3 FS-105
- 1.4.4 GDC-0575
- 1.4.5 Others
- 1.5 Market by End User
- 1.5.1 Global Serine/Threonine Protein Kinase Chk1 Market Size Growth Rate by End User
- 1.5.2 Clinic
- 1.5.3 Hospital
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Serine/Threonine Protein Kinase Chk1 Market Size
- 2.1.1 Global Serine/Threonine Protein Kinase Chk1 Revenue 2014-2025
- 2.1.2 Global Serine/Threonine Protein Kinase Chk1 Sales 2014-2025
- 2.2 Serine/Threonine Protein Kinase Chk1 Growth Rate by Regions
- 2.2.1 Global Serine/Threonine Protein Kinase Chk1 Sales by Regions
- 2.2.2 Global Serine/Threonine Protein Kinase Chk1 Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Serine/Threonine Protein Kinase Chk1 Sales by Manufacturers
- 3.1.1 Serine/Threonine Protein Kinase Chk1 Sales by Manufacturers
- 3.1.2 Serine/Threonine Protein Kinase Chk1 Sales Market Share by Manufacturers
- 3.1.3 Global Serine/Threonine Protein Kinase Chk1 Market Concentration Ratio (CR5 and HHI)
- 3.2 Serine/Threonine Protein Kinase Chk1 Revenue by Manufacturers
- 3.2.1 Serine/Threonine Protein Kinase Chk1 Revenue by Manufacturers (2014-2019)
- 3.2.2 Serine/Threonine Protein Kinase Chk1 Revenue Share by Manufacturers (2014-2019)
- 3.3 Serine/Threonine Protein Kinase Chk1 Price by Manufacturers
- 3.4 Serine/Threonine Protein Kinase Chk1 Manufacturing Base Distribution, Product Types
- 3.4.1 Serine/Threonine Protein Kinase Chk1 Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Serine/Threonine Protein Kinase Chk1 Product Type
- 3.4.3 Date of International Manufacturers Enter into Serine/Threonine Protein Kinase Chk1 Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Serine/Threonine Protein Kinase Chk1 Sales by Product
- 4.2 Global Serine/Threonine Protein Kinase Chk1 Revenue by Product
- 4.3 Serine/Threonine Protein Kinase Chk1 Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Serine/Threonine Protein Kinase Chk1 Breakdown Data by End User
6 North America
- 6.1 North America Serine/Threonine Protein Kinase Chk1 by Countries
- 6.1.1 North America Serine/Threonine Protein Kinase Chk1 Sales by Countries
- 6.1.2 North America Serine/Threonine Protein Kinase Chk1 Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Serine/Threonine Protein Kinase Chk1 by Product
- 6.3 North America Serine/Threonine Protein Kinase Chk1 by End User
7 Europe
- 7.1 Europe Serine/Threonine Protein Kinase Chk1 by Countries
- 7.1.1 Europe Serine/Threonine Protein Kinase Chk1 Sales by Countries
- 7.1.2 Europe Serine/Threonine Protein Kinase Chk1 Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Serine/Threonine Protein Kinase Chk1 by Product
- 7.3 Europe Serine/Threonine Protein Kinase Chk1 by End User
8 Asia Pacific
- 8.1 Asia Pacific Serine/Threonine Protein Kinase Chk1 by Countries
- 8.1.1 Asia Pacific Serine/Threonine Protein Kinase Chk1 Sales by Countries
- 8.1.2 Asia Pacific Serine/Threonine Protein Kinase Chk1 Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Serine/Threonine Protein Kinase Chk1 by Product
- 8.3 Asia Pacific Serine/Threonine Protein Kinase Chk1 by End User
9 Central & South America
- 9.1 Central & South America Serine/Threonine Protein Kinase Chk1 by Countries
- 9.1.1 Central & South America Serine/Threonine Protein Kinase Chk1 Sales by Countries
- 9.1.2 Central & South America Serine/Threonine Protein Kinase Chk1 Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Serine/Threonine Protein Kinase Chk1 by Product
- 9.3 Central & South America Serine/Threonine Protein Kinase Chk1 by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Serine/Threonine Protein Kinase Chk1 by Countries
- 10.1.1 Middle East and Africa Serine/Threonine Protein Kinase Chk1 Sales by Countries
- 10.1.2 Middle East and Africa Serine/Threonine Protein Kinase Chk1 Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Serine/Threonine Protein Kinase Chk1 by Product
- 10.3 Middle East and Africa Serine/Threonine Protein Kinase Chk1 by End User
11 Company Profiles
- 11.1 CanBas Co Ltd
- 11.1.1 CanBas Co Ltd Company Details
- 11.1.2 Company Business Overview
- 11.1.3 CanBas Co Ltd Serine/Threonine Protein Kinase Chk1 Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 CanBas Co Ltd Serine/Threonine Protein Kinase Chk1 Products Offered
- 11.1.5 CanBas Co Ltd Recent Development
- 11.2 Cascadian Therapeutics Inc
- 11.2.1 Cascadian Therapeutics Inc Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Cascadian Therapeutics Inc Serine/Threonine Protein Kinase Chk1 Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Cascadian Therapeutics Inc Serine/Threonine Protein Kinase Chk1 Products Offered
- 11.2.5 Cascadian Therapeutics Inc Recent Development
- 11.3 Eli Lilly and Company
- 11.3.1 Eli Lilly and Company Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Eli Lilly and Company Serine/Threonine Protein Kinase Chk1 Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Eli Lilly and Company Serine/Threonine Protein Kinase Chk1 Products Offered
- 11.3.5 Eli Lilly and Company Recent Development
- 11.4 Genentech Inc
- 11.4.1 Genentech Inc Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Genentech Inc Serine/Threonine Protein Kinase Chk1 Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Genentech Inc Serine/Threonine Protein Kinase Chk1 Products Offered
- 11.4.5 Genentech Inc Recent Development
- 11.5 ProNAi Therapeutics Inc
- 11.5.1 ProNAi Therapeutics Inc Company Details
- 11.5.2 Company Business Overview
- 11.5.3 ProNAi Therapeutics Inc Serine/Threonine Protein Kinase Chk1 Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 ProNAi Therapeutics Inc Serine/Threonine Protein Kinase Chk1 Products Offered
- 11.5.5 ProNAi Therapeutics Inc Recent Development
- 11.6 Sareum Holdings Plc
- 11.6.1 Sareum Holdings Plc Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Sareum Holdings Plc Serine/Threonine Protein Kinase Chk1 Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Sareum Holdings Plc Serine/Threonine Protein Kinase Chk1 Products Offered
- 11.6.5 Sareum Holdings Plc Recent Development
- 11.7 Vernalis Plc
- 11.7.1 Vernalis Plc Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Vernalis Plc Serine/Threonine Protein Kinase Chk1 Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Vernalis Plc Serine/Threonine Protein Kinase Chk1 Products Offered
- 11.7.5 Vernalis Plc Recent Development
12 Future Forecast
- 12.1 Serine/Threonine Protein Kinase Chk1 Market Forecast by Regions
- 12.1.1 Global Serine/Threonine Protein Kinase Chk1 Sales Forecast by Regions 2019-2025
- 12.1.2 Global Serine/Threonine Protein Kinase Chk1 Revenue Forecast by Regions 2019-2025
- 12.2 Serine/Threonine Protein Kinase Chk1 Market Forecast by Product
- 12.2.1 Global Serine/Threonine Protein Kinase Chk1 Sales Forecast by Product 2019-2025
- 12.2.2 Global Serine/Threonine Protein Kinase Chk1 Revenue Forecast by Product 2019-2025
- 12.3 Serine/Threonine Protein Kinase Chk1 Market Forecast by End User
- 12.4 North America Serine/Threonine Protein Kinase Chk1 Forecast
- 12.5 Europe Serine/Threonine Protein Kinase Chk1 Forecast
- 12.6 Asia Pacific Serine/Threonine Protein Kinase Chk1 Forecast
- 12.7 Central & South America Serine/Threonine Protein Kinase Chk1 Forecast
- 12.8 Middle East and Africa Serine/Threonine Protein Kinase Chk1 Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Serine/Threonine Protein Kinase Chk1 Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Serine/Threonine Protein Kinase Chk1 . Industry analysis & Market Report on Serine/Threonine Protein Kinase Chk1 is a syndicated market report, published as Global Serine/Threonine Protein Kinase Chk1 Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Serine/Threonine Protein Kinase Chk1 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
